Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arcus Biosciences (RCUS) Return on Equity (2018 - 2025)

Historic Return on Equity for Arcus Biosciences (RCUS) over the last 8 years, with Q3 2025 value amounting to 0.69%.

  • Arcus Biosciences' Return on Equity fell 2400.0% to 0.69% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.69%, marking a year-over-year decrease of 2400.0%. This contributed to the annual value of 0.6% for FY2024, which is 500.0% down from last year.
  • Arcus Biosciences' Return on Equity amounted to 0.69% in Q3 2025, which was down 2400.0% from 0.55% recorded in Q2 2025.
  • Arcus Biosciences' Return on Equity's 5-year high stood at 0.11% during Q3 2022, with a 5-year trough of 0.77% in Q1 2025.
  • For the 5-year period, Arcus Biosciences' Return on Equity averaged around 0.37%, with its median value being 0.44% (2023).
  • In the last 5 years, Arcus Biosciences' Return on Equity soared by 6000bps in 2022 and then crashed by -6500bps in 2023.
  • Over the past 5 years, Arcus Biosciences' Return on Equity (Quarter) stood at 0.08% in 2021, then crashed by -614bps to 0.39% in 2022, then crashed by -59bps to 0.63% in 2023, then rose by 14bps to 0.54% in 2024, then decreased by -28bps to 0.69% in 2025.
  • Its Return on Equity stands at 0.69% for Q3 2025, versus 0.55% for Q2 2025 and 0.77% for Q1 2025.